小剂量多巴胺与羟乙基淀粉溶液联合治疗重度卵巢过度刺激综合征的临床观察被引量：5

Effect of Low Dose Dopamine and Intravenous Hydroxyethyl Starchon Severe Ovarian Hyperstimulation Syndrome

在线阅读下载PDF

导出

摘要目的：探讨小剂量多巴胺与羟乙基淀粉溶液联合治疗重度卵巢过度刺激综合征的临床疗效。方法：选择重度卵巢过度刺激综合征（OHSS）患者60例,使用随机数字法分为两组,对照组30例采用羟乙基淀粉溶液500-1000 ml/d,静脉滴注10-14天,同时采用白蛋白加胸腹腔积液抽吸治疗;治疗组30例在对照组治疗方法的基础上同时加用小剂量多巴胺40 mg/d（2μg/kg·min）,静脉滴注,用药7-10天。观察并比较两组患者血生化相关指标及住院时间、住院费用等的差异。结果：治疗组总蛋白、白蛋白的疗效优于对照组,差异有统计学意义（P〈0.01）。治疗组尿量恢复时间、血细胞比容恢复时间、住院时间明显比对照组短,差异有统计学意义（P〈0.01,P〈0.05）。治疗组住院费用明显比对照组低,差异有统计学意义（P〈0.01）。两组治疗后均能有效改善OHSS症状、体征和血液生化指标。白细胞、尿素氮、肌酐、丙氨酸氨基转移酶（ALT）、天门冬氨酸氨基转移酶（AST）、钾、钠治疗前后比较,差异无统计学意义（P〉0.05）。结论：重度OHSS患者应用小剂量多巴胺与羟乙基淀粉溶液联合治疗,能迅速缓解症状,缩短住院时间,降低住院费用及减少并发症的发生,为治疗OHSS的一种有效方法。 Objective： To explore the clinical effect of low dose dopamine and intravenoushydroxyethyl starch on severe ovarian hyperstimulation syndrome（ OHSS）. Methods： 60 cases with severe OHSS were enrolled and randomly divided into two groups. 30 patients in control group were treated with intravenous hydroxyethyl starch（ HES） 500 -1000 ml/d for 10 to 14 days,and albumin combined with aspiration of pleural effusion and seroperitoneum. 30 patients in treatment group were treated with low dose dopamine 40 mg / d[2 μg /（ kg·min） ] for 7 to10 days,as well as the treatment in control group. The changes in blood biochemical parameters,hospitalization time and cost were compared between two groups. Results： The levels of total protein and albumin in treatment group were significantly higher than those in control group（ P〈0. 01）. The urine volume recovery time,hematocrit recovery time,and hospitalization time in treatment group were significantly shorter than those in control group（ P〈0. 01,P〈0. 05）. The hospitalization cost in treatment group was significantly lower than that in control group（ P〈0. 01）. The symptoms,signs of OHSS and blood biochemical parameters improved in both two groups. There was no significant difference in the level of white blood cell,urea nitrogen,creatinine,potassium or sodium between both groups（ P〈0. 05）. Conclusions： Low dose dopamine and intravenous hydroxyethyl starch can quickly improve the symptoms,shorten the hospitalization time,reduce hospitalization costs and reduce complications of OHSS,suggesting it should be an effective approach for OHSS.

作者夏一丹谢兰周飞

机构地区四川省医学科学院.四川省人民医院

出处《实用妇产科杂志》 CAS CSCD 北大核心 2015年第5期354-357,共4页 Journal of Practical Obstetrics and Gynecology

关键词卵巢过度刺激综合征多巴胺羟乙基淀粉溶液 Ovarian hyperstimulation syndrome Dopamine Intravenous hydroxyethyl starch

分类号 R711.75 [医药卫生—妇产科学]

作者简介通讯作者：谢兰，Email：xielan1019@yahoo．cn

引文网络
相关文献

参考文献8

1Marzal A, Holzer I-I, Tulandi T. Future developments to minimize ART risks [ J ]. Semin Reprod Med,2012,30 ( 2 ) : 152 - 160.
2Golan A, Ron EIR, Herman A, et al. Ovarian hyperstimulat ion syn- drome : an update review [ J ]. Obst et Gynecol Surv, 1989,44 ( 6 ) : 430 - 433.
3Busso CE, Gareia Velaseo J, Gomez R, et al. Symposium: update on prediction and management of OHSS. Prevention of OHSS-dopamiue agonists[ J]. Reprod Biomed Online ,2009,19 ( 1 ) :43 - 51.
4Orvieto R. Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome [ J ]. Hum Reprod,2007,22( 11 ) :3042.
5Soares SR. Etiology of OHSS and use of dopamine agonists[ J]. Fertil Steril,2012,97(3) :517 -522.
6舒晓巍,王莉云.万汶用于重度卵巢过度刺激综合征并发胸腹腔积液预防及治疗中的疗效分析[J].中国妇幼保健,2014,29(25):4110-4113. 被引量：8
7倪亚莉,柴三明,郭佩兰,邓伟.羟乙基淀粉溶液预防卵巢过度刺激综合征的系统评价[J].实用妇产科杂志,2013,29(7):539-542. 被引量：5
8肖开转,王凡,吴荔香,谢祈琪,王正朝.多巴胺在卵巢过度刺激综合征治疗中的应用[J].动物医学进展,2013,34(11):110-113. 被引量：8

二级参考文献51

1Youssef MA,A1-Inany HG,Evers JL,et al. Intra-venous fluids for theprevention of severe ovarian hyperstimulation syndrome[ J]. CochraneDatabase Syst Rev,2011,16(2) :CD001302.
2Jee BC,Suh CS,Kim YB,et al. Administration of intravenous albuminaround the time of oocyte retrieval reduces pregnancy rate without pre-venting ovarian hyperstimulation syndrome: a systematic review andmeta-analysis[ J]. Gynecol Obstet Invest ,2010,70( 1 ) :47 -54.
3Venetis CA, Kolibianakis EM, Toulis KA, et al. Intravenous albuminadministration for the prevention of sever ovarian hyperstimulationsyndrome : A systematic review and meta-analysis [ J]. Fertil Steril,2011,95(1) :188 -196.
4Aboulghar MA,Mansour RT. Ovarian hyperstimulation syndrome:clas-sifications and critical analysis of preventive measures[ J]. Hum Re-prod Update,2003,9(3) :275 -289.
5Brinsden P. A textbook of in vitro fertilization and assisted reproduc-tion [M]. 2nd ed. London : Parthenon Publishing Group, 1999 :131 -135.
6Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hy-perstimulation syndrome : guidance for the clinician [ J]. Fertil Steril,2010,94(2) :389 -400.
7Lamazou F, Legouez A, Letouzey V, et al. Ovarian hyperstimulationsyndrome : pathophysiology,risk factors, prevention,diagnosis andtreatment [ J]. J Gynecol Obstet Biol Reprod ( Paris ) , 2011 ,40 ( 7 ):593 -611.
8Higgins JPT, Green S. Cochrane handbook for systematic reviews ofinterventions: version 5.1.0 Cochrane Collaboration [ J].2011.http://www. cochrane-handbook. org.
9Konig E,Bussen S,Siitterlin M,et al. Prophylactic intravenous hydroxy-ethyle starch solution prevents moderate-severe ovarian hyperstimula-tion in in-vitro fertilization patients: a prospective, randomized, doub-le-blind and placebo-controlled study[ J]. Hum Reprod, 1998 ,13 (9):2421 -2424.
10Gokmen O, Ugur M,Ekin M, et al. Intravenous albumin versushydroxyethyl starch for the prevention of ovarian hyperstimulation inan in-vitro fertilisation programme: a prospective randomised placebocontrolled study [ J]. Eur J Obstet Gynecol Reprod Biol, 2001,96(2):187~192.